Dr. Rhaisa Amelia Dumenigo, MD

Dr. Dumenigo practices at Larkin Hospital South Miami in South Miami, Florida, part of Larkin Community Hospital.

Dr. Dumenigo's NPI, 1225248628, was assigned on May 23, 2007. Dr. Dumenigo graduated from Universidad Central del Este Facultad de Medicina in 1985. Dr. Dumenigo holds Florida license ME106033.

Dr. Dumenigo's primary practice is Larkin Hospital South Miami, at 7031 Sw 62nd Ave, South Miami, FL 33143 in Miami-Dade County. The practice phone is (305) 284-7500.

Dr. Dumenigo's primary practice is Larkin Hospital South Miami in South Miami, Florida, part of Larkin Community Hospital. Dr. Dumenigo is also affiliated with Larkin Hospital Palm Springs. The medical group on file is First Docs. Dmand AI also links Dr. Dumenigo to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dumenigo practices, 4 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Dumenigo's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Dumenigo is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dr. Dumenigo is licensed in Florida.

Dmand AI lists anxiety, bipolar disorder, depression, psychoses and schizophrenia among the conditions Dr. Dumenigo treats.

CMS data shows 965 Medicare services from Dr. Dumenigo across 5 procedure codes in 2024, for 214 Medicare patients. Medicare paid $71,749 for them.

CMS counts 214 Medicare patients who saw Dr. Dumenigo in 2024. The largest group is under 65, with 76 patients. 75% of them have anxiety, and 75% have high blood pressure. 86% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dumenigo's median patient age at 64, with 53% women.

In 2024, Dr. Dumenigo wrote 6,771 Medicare Part D claims for 358 patients. 96% of them were for generic drugs. CMS names the drug for 6,674 of them, across 40 drugs with 11 or more claims each, at $285,789 in total drug cost. In 2023, CMS named 6,571 claims across 41 drugs.

Dr. Dumenigo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dumenigo as offering telehealth.

Dmand AI links 4 papers to Dr. Dumenigo, published from 2015 to 2018. 2016 was the busiest year, with 2. Dr. Dumenigo has published most often in Case Rep Psychiatry. Dr. Dumenigo's most frequent co-authors are Gerardo Francisco Ferrer, MD, Patricia Junquera, MD and Samir Alkabie, MD, MS.

CMS Open Payments shows 120 general payments to Dr. Dumenigo from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $1,088.

Dr. Dumenigo graduated from Universidad Central del Este Facultad de Medicina in 1985.

Dr. Dumenigo is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.